CEDD: Coaching and Education for Diabetes Distress

Sponsor
Baylor College of Medicine (Other)
Overall Status
Terminated
CT.gov ID
NCT03617146
Collaborator
(none)
19
1
2
27.1
0.7

Study Details

Study Description

Brief Summary

Diabetes distress (DD) is a negative emotional reaction to a diagnosis of diabetes and concerns about the burden of managing diabetes, the risk of complications, and inadequate support system. DD is common among people with diabetes and is strongly associated with poor diabetes self-care and poor diabetes control. Reducing DD should thus be an important component of diabetes management. In line with the growing evidence, the American Diabetes Association now recommends that providers "routinely monitor people with diabetes for diabetes distress, particularly when treatment targets are not met". Despite increased recognition of the need to manage DD, interventions that are both feasible and effective for reducing DD in routine care settings are not yet known. A pilot study showed that health coaching (HC) has some efficacy in addressing DD but no adequately powered study has implemented a pragmatic research design capable of assessing the real-world effectiveness of HC in reducing DD.

This study seeks to assess whether HC effectively reduces DD among primary care patients with diabetes, and whether HC is more effective than an educational program targeting DD. The investigators hypothesize that over a 6-month period, patients with poorly controlled diabetes and DD who enroll in and complete at least five HC sessions will achieve higher and clinically significant reductions in DD and HbA1c, and greater compliance with diabetes self-care recommendations than those who receive only an educational program targeting DD as part of usual diabetes care.

The two-arm randomized controlled trial for patients with poorly-controlled diabetes is taking place at an academic family medicine practice in Houston, Texas. Both arms will receive usual care, which includes education about DD. In addition, the intervention arm will receive eight HC sessions over a five-month period. The primary outcome measure is reduction in DD over a six month period. Additional outcome measures include changes in glycemic control (HbA1C) and self-care practices (medication adherence, dietary, and physical activity behaviors). The study will also measure satisfaction and willingness-to-pay for HC to determine the extent to which HC, if effective for reducing DD, can be operationalized in similar healthcare settings.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health coaching
  • Other: Diabetes Distress-specific Education
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
19 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-arm parallel randomized controlled trialTwo-arm parallel randomized controlled trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Due to the nature of the behavioral intervention, neither participants nor clinic staff can be blinded to allocation. However, to avoid bias in assessing outcomes, the analyst who will abstract the outcomes data from the electronic health record will not have access to information about the allocation. Hence retrieval of data on baseline and follow up diabetes distress scores, HbA1c, and diabetes self-management behaviors, and the creation of the analysis dataset will be done without knowledge or consideration of allocation status.
Primary Purpose:
Supportive Care
Official Title:
Coaching and Education for Diabetes Distress: a Randomized Controlled Trial (CEDD Trial)
Actual Study Start Date :
Jun 15, 2018
Actual Primary Completion Date :
Feb 25, 2020
Actual Study Completion Date :
Sep 17, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Arm

Participants in the intervention arm will receive the following interventions: Month 1: Diabetes Distress-specific Education. Months 1 to 3: Six 30 to 45-minute telephone-based health coaching sessions targeting diabetes distress reduction and self-care improvement. Month 3: Follow up distress-specific education. Months 4 and 5: Two 30 to 45 minute telephone-based health coaching sessions targeting diabetes distress reduction and self-care improvement.

Behavioral: Health coaching
The intervention will seek to help participants express their diabetes emotional needs and to work with them to figure out what can be done to meet those needs. Depending on the unique needs of each participant, the coaching approach for this study will include: improving motivation and self-efficacy for diabetes management using motivational interviewing and appreciative inquiry; building trust and rapport through mindful listening, open-ended inquiry, and perceptive reflections; and expressing empathy through nonviolent communication. Each participant will receive eight individual coaching sessions over a five month period. All coaching sessions will be delivered over the phone (i.e. telecoaching). The coaching intervention will be done by a certified health and wellness coach.
Other Names:
  • Telecoaching
  • Other: Diabetes Distress-specific Education
    A diabetes distress-specific education that explains what diabetes distress is, why it matters, and its four domains. In addition, the participant is given feedback on his or her distress score and advised on ways to deal with the areas of greatest distress. Participant is linked with resources to overcome any expressed needs. The education is provided by a trained medical assistant.

    Active Comparator: Control Arm

    Participants in the control arm will receive the following interventions: Month 1: Diabetes Distress-specific Education (same as for the intervention arm). Month 3: Follow up distress-specific education (same as for the intervention arm).

    Other: Diabetes Distress-specific Education
    A diabetes distress-specific education that explains what diabetes distress is, why it matters, and its four domains. In addition, the participant is given feedback on his or her distress score and advised on ways to deal with the areas of greatest distress. Participant is linked with resources to overcome any expressed needs. The education is provided by a trained medical assistant.

    Outcome Measures

    Primary Outcome Measures

    1. Diabetes distress score [3 months and 6 months from baseline]

      Change in diabetes distress score as measured by the diabetes distress scale (DDS). DDS scores range from 1 to 6, with scores that are less than 2.0 being indicative of little or no distress. Hence scores of 2.0 and above are significant and higher values are indicative of worse outcome.

    Secondary Outcome Measures

    1. HbA1c [3 months and 6 months from baseline]

      Change in glycemic control as measured by HbA1c

    2. Self-care behaviors (medication adherence, dietary practices, and physical activity behaviors) [3 months and 6 months from baseline]

      Change in medication adherence, dietary practices, and physical activity behaviors, as measured by the respective medication, diet, and exercise subscales of the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Has had a diagnosis of type 2 diabetes for at least 6 months

    • Aged 18 to 75 years

    • Most recent HbA1c taken within 30 days was ≥ 8.0

    • At least moderate diabetes distress (a mean score ≥ 2.0 on the 17-item Diabetes Distress Scale).

    Exclusion Criteria:
    • Moderately-severe to severe depression: Patient Health Questionnaire (PHQ9) score ≥15

    • Other severe mental health disorder (e.g. Alzheimer's, schizophrenia)

    • Current pregnancy

    • Severe diabetes complications or functional deficits (e.g. kidney failure requiring dialysis, amputation, blindness).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Baylor Family Medicine Houston Texas United States 77098

    Sponsors and Collaborators

    • Baylor College of Medicine

    Investigators

    • Principal Investigator: Charles Chima, Baylor College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Charles C Chima, Adjunct Assistant Professor, Baylor College of Medicine
    ClinicalTrials.gov Identifier:
    NCT03617146
    Other Study ID Numbers:
    • 52960-I
    First Posted:
    Aug 6, 2018
    Last Update Posted:
    Jan 22, 2021
    Last Verified:
    Jan 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Charles C Chima, Adjunct Assistant Professor, Baylor College of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 22, 2021